Angiozyme is a substance that is being studied in the treatment of kidney cancer. It may prevent the growth of blood vessels from surrounding tissue to the tumor. It belongs to the families of drugs called VEGF receptor and angiogenesis inhibitors. Also called RPI.4610.
- Angiozyme entry in the public domain NCI Dictionary of Cancer Terms
|This oncology article is a stub. You can help Wikipedia by expanding it.|